The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Copper complexes as therapeutic agents
Abstract
The importance of transition metals in biological processes has been well established. Copper (Cu) is a transition metal that can exist in oxidised and reduced states. This allows it to participate in redox and catalytic chemistry, making it a suitable cofactor for a diverse range of enzymes and molecules. Cu deficiency or toxicity is implicated in a variety of pathological conditions; therefore inorganic complexes of Cu have been investigated for their therapeutic and diagnostic potential. These Cu complexes have been shown to be effective in cancer treatment due to their cytotoxic action on tumour cells. Alternatively, Cu complexes can also modulate Cu homeostasis in the brain, resulting in protective effects in several models of neurodegeneration. In other diseases such as coronary heart disease and skin disease, the success of Cu complexes as potential therapeutics will most likely be due to their ability to increase SOD activity, leading to relief of oxidative stress. This review seeks to provide a broad insight into some of the diverse actions of Cu complexes and demonstrate the strong future for these compounds as potential therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
García Rodríguez, L., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 975
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
The Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes
(2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487484 · Cited by 777
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
Oates, J. A., Wood, A. J. J., Brooks, P. M., & Day, R. O. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242407 · Cited by 775
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
Petris, M. J., Mercer, J. F., Culvenor, J. G., Lockhart, P., Gleeson, P. A., & Camakaris, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00997.x · Cited by 638
Drug discovery in the ubiquitin–proteasome system
Nalepa, G., Rolfe, M., & Harper, J. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2056 · Cited by 608
Arredondo, M., & Núñez, M. T. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.010 · Cited by 550
Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
Weder, J. E., Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Biffin, J. R., Regtop, H. L., & Davies, N. M. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00086-3 · Cited by 536
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475
Deng, H.-X., Shi, Y., Furukawa, Y., Zhai, H., Fu, R., Liu, E., Gorrie, G. H., Khan, M. S., Hung, W.-Y., Bigio, E. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602046103 · Cited by 431
2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents
Klayman, D. L., Bartosevich, J. F., Griffin, T. S., Mason, C. J., & Scovill, J. P. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00193a020 · Cited by 427
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Faux, N. G., Ritchie, C. W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1390 · Cited by 405
Adsule, S., Barve, V., Chen, D., Ahmed, F., Dou, Q. P., Padhye, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060712l · Cited by 334
Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R., & Dou, Q. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1322 · Cited by 326
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis, J. S., Mccarthy, D. W., McCarthy, T. J., et al. (1999) · PubMed · Cited by 323
Brewer, G. J., Askari, F., Lorincz, M. T., Carlson, M., Schilsky, M., Kluin, K. J., Hedera, P., Moretti, P., Fink, J. K., Tankanow, R., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.521 · Cited by 322
Cellular Copper Transport and Metabolism
Harris, E. D. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.291 · Cited by 314
Kardos, J., Kovács, I., Hajós, F., Kálmán, M., & Simonyi, M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90565-x · Cited by 302
Paterson, B. M., & Donnelly, P. S. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00215a · Cited by 299
Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., & Zatta, P. (2004) · Inorganic Chemistry · doi:10.1021/ic0494051 · Cited by 292
Dexter, D. T., Jenner, P., Schapira, A. H. V., Marsden, C. D., & The Royal Kings and Queens Parkinson's Disease Research Group (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292
White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284
Self-citationPreclinical Perspectives on Platinum Resistance
Kelland, L. R. (2000) · Drugs · doi:10.2165/00003495-200059004-00001 · Cited by 280
Roelofsen, H., Wolters, H., Van Luyn, M. J. A., Miura, N., Kuipers, F., & Vonk, R. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.17834 · Cited by 279
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Crouch, P. J., Hung, L. W., Adlard, P. A., Cortes, M., Lal, V., Filiz, G., Perez, K. A., Nurjono, M., Caragounis, A., Du, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809057106 · Cited by 278
Self-citationCopper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
Dearling, J. L. J., Lewis, J. S., Mullen, G. E. D., Welch, M. J., & Blower, P. J. (2002) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100291 · Cited by 277
Mutant SOD1 causes motor neuron disease independent of copper chaperone–mediated copper loading
Subramaniam, J. R., Lyons, W. E., Liu, J., Bartnikas, T. B., Rothstein, J., Price, D. L., Cleveland, D. W., Gitlin, J. D., & Wong, P. C. (2002) · Nature Neuroscience · doi:10.1038/nn823 · Cited by 267
Schrag, M., Mueller, C., Oyoyo, U., Smith, M. A., & Kirsch, W. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.001 · Cited by 263
The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis
Hamza, I., Faisst, A., Prohaska, J., Chen, J., Gruss, P., & Gitlin, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111058498 · Cited by 247
Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia
Vāvere, A. L., & Lewis, J. S. (2007) · Dalton Transactions · doi:10.1039/b705989b · Cited by 245
Copper in Medicine: Homeostasis, Chelation Therapy and Antitumor Drug Design
Wang, T., & Guo, Z. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776055742 · Cited by 233
Cathcart, M. K., McNally, A. K., Morel, D. W., & Chisolm, G. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.6.1963 · Cited by 226
Mechanisms of Copper Ion Mediated Huntington's Disease Progression
Fox, J. H., Kama, J. A., Lieberman, G., Chopra, R., Dorsey, K., Chopra, V., Volitakis, I., Cherny, R. A., Bush, A. I., & Hersch, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000334 · Cited by 216
Copper-64-diacetyl-bis( N 4 -methylthiosemicarbazone): An agent for radiotherapy
Lewis, J. S., Laforest, R., Buettner, T. L., Song, S.-K., Fujibayashi, Y., Connett, J. M., & Welch, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1206 · Cited by 213
Chen, D., Cui, Q. C., Yang, H., Barrea, R. A., Sarkar, F. H., Sheng, S., Yan, B., Reddy, G. P. V., & Dou, Q. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3546 · Cited by 212
Scheinberg, I. H., Jaffe, M. E., & Sternlieb, I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170405 · Cited by 208
Increased cholesterol in plasma in a young man during experimental copper depletion
Klevay, L. M., Inman, L., Johnson, L. K., Lawler, M., Mahalko, J. R., Milne, D. B., Lukaski, H. C., Bolonchuk, W., & Sandstead, H. H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90096-9 · Cited by 201
Matusch, A., Depboylu, C., Palm, C., Wu, B., Höglinger, G. U., Schäfer, M. K. H., & Becker, J. S. (2010) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2009.09.022 · Cited by 197
Chelators at the cancer coalface: Desferrioxamine to Triapine and beyond
Yu, Y., Wong, J., Lovejoy, D. B., Kalinowski, D. S., & Richardson, D. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1954 · Cited by 195
Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q.-X., Masters, C. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705957200 · Cited by 195
Self-citationNguyen, T., Hamby, A., & Massa, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502177102 · Cited by 194
Lee, J.-Y., Friedman, J. E., Angel, I., Kozak, A., & Koh, J.-Y. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.005 · Cited by 191
Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity
Schlief, M. L., West, T., Craig, A. M., Holtzman, D. M., & Gitlin, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605390103 · Cited by 184
Maquart, F.-X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.-C., & Borel, J.-P. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80509-x · Cited by 181
Rw, B., THOMSON, J. R., BELL, M. J., & He, S. (1956) · PubMed · Cited by 178
Boll, M.-C., Alcaraz-Zubeldia, M., Montes, S., & Rios, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9610-3 · Cited by 173
Forbes, J. R., Hsi, G., & Cox, D. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12408 · Cited by 166
GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration
Salcedo-Tello, P., Ortiz-Matamoros, A., & Arias, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189728 · Cited by 166
Malm, T., Iivonen, H., Goldsteins, G., Keksa-Goldsteine, V., Ahtoniemi, T., Kanninen, K. M., Salminen, A., Auriola, S. O. K., van Groen, T., Tanila, H., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0059-07.2007 · Cited by 158
Transition Metal Based Anticancer Drugs
Garbutcheon‐Singh, K. B., Grant, M. P., Harper, B. W. J., Krause‐Heuer, A. M., Manohar, M., Orkey, N., & Aldrich-Wright, J. R. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794785226 · Cited by 150
Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein
Kuzuya, M., Yamada, K., Hayashi, T., FUNAKI, C., Naito, M., Asai, K., & Kuzuya, F. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90015-n · Cited by 144
Metal ionophores – An emerging class of anticancer drugs
Ding, W., & Lind, S. E. (2009) · IUBMB Life · doi:10.1002/iub.253 · Cited by 143
Zhai, S., Yang, L., Cui, Q. C., Sun, Y., Dou, Q. P., & Yan, B. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0594-5 · Cited by 137
Andreassen, O. A., Dedeoglu, A., Klivènyi, P., Beal, M. F., & Bush, A. I. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00029 · Cited by 135
Mao, X., & Schimmer, A. D. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.08.015 · Cited by 129
In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese
TENAUD, SAINTE-MARIE, JUMBOU, LITOUX, & DRÉNO (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02603.x · Cited by 126
Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
Kheirolomoom, A., Mahakian, L. M., Lai, C.-Y., Lindfors, H. A., Seo, J. W., Paoli, E. E., Watson, K. D., Haynam, E. M., Ingham, E. S., Li, X., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100245u · Cited by 124
Adlard, P. A., Bica, L., White, A. R., Nurjono, M., Filiz, G., Crouch, P. J., Donnelly, P. S., Cappai, R., Finkelstein, D. I., & Bush, A. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017669 · Cited by 123
Self-citationHancock, C. N., Stockwin, L. H., Han, B., Divelbiss, R. D., Jun, J. H., Malhotra, S. V., Hollingshead, M. G., & Newton, D. L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.696 · Cited by 120
Dierick, H. A., Adam, A. N., Escara-Wilke, J. F., & Glover, T. W. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.409 · Cited by 120
Ctr1 and its role in body copper homeostasis
Sharp, P. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00134-6 · Cited by 118
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma
Mao, X., Li, X., Sprangers, R., Wang, X., Venugopal, A. L., Wood, T. E., Zhang, Y., Kuntz, D. A., Coe, E., Trudel, S., et al. (2008) · Leukemia · doi:10.1038/leu.2008.232 · Cited by 117
Photoaging and chronological aging profile: Understanding oxidation of the skin
Peres, P. S., Terra, V. A., Guarnier, F. A., Cecchini, R., & Cecchini, A. L. (2011) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2011.01.019 · Cited by 112
Serum copper and related variables in rheumatoid arthritis.
Scudder, P. R., Al-Timimi, D. J., McMurray, W., White, A. G., Zoob, B. C., & Dormandy, T. L. (1978) · Annals of the Rheumatic Diseases · doi:10.1136/ard.37.1.67 · Cited by 110
Self-citationChakraborty, A., Kumar, P., Ghosh, K., & Roy, P. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.003 · Cited by 109
Ainscough, E. W., Brodie, A. M., Denny, W. A., Finlay, G. J., Gothe, S. A., & Ranford, J. D. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00131-2 · Cited by 94
Berthon, G. (1993) · Inflammation Research · doi:10.1007/bf01998975 · Cited by 91
Jones, A. A., DiSilvestro, R. A., Coleman, M., & Wagner, T. L. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90135-9 · Cited by 88
ATP7A (Menkes protein) functions in axonal targeting and synaptogenesis
Meskini, R. E., Crabtree, K. L., Cline, L. B., Mains, R. E., Eipper, B. A., & Ronnett, G. V. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.018 · Cited by 82
Yasumatsu, N., Yoshikawa, Y., Adachi, Y., & Sakurai, H. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.062 · Cited by 81
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm
Khan, G. N., & Merajver, S. D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902845622 · Cited by 80
Biphasic effects of copper on neurotransmission in rat hippocampal neurons
Peters, C., Muñoz, B., Sepúlveda, F. J., Urrutia, J. C., Quiroz, M., Luza, S., Ferrari, G. V. D., Aguayo, L. G., & Opazo, C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07417.x · Cited by 79
Tokuda, E., Ono, S.-I., Ishige, K., Watanabe, S., Okawa, E., Ito, Y., & Suzuki, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.011 · Cited by 73
Siméon, A., Monier, F., Emonard, H., Gillery, P., Hornebeck, W., Maquart, F.-X., & Birembaut, P. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00606.x · Cited by 68
Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM)
Sitasawad, S. L., Deshpande, M. S., Katdare, M., Tirth, S., & Parab, P. B. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00249-7 · Cited by 63
Omoto, A., Kawahito, Y., Prudovsky, I. A., Tubouchi, Y., Kimura, M., Ishino, H., Wada, M., Yoshida, M., Kohno, M., Yoshimura, R., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1801 · Cited by 59
Cangul, I. T., Gul, N. Y., Topal, A., & Yilmaz, R. (2006) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2006.00551.x · Cited by 57
Sasaki, H., Akamatsu, H., & Horio, T. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb01914.x · Cited by 57
Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease
Hands, S. L., Mason, R. P., Sajjad, M. U., Giorgini, F., & Wyttenbach, A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380552 · Cited by 55
Petri, S., Calingasan, N. Y., Alsaied, O. A., Wille, E., Kiaei, M., Friedman, J. E., Baranova, O., Chavez, J. C., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04604.x · Cited by 55
Miller, D. B., Reinhard, J. F., Daniels, A. J., & O'Callaghan, J. P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03784.x · Cited by 53
Measurement of Copper-Binding Sites on Low Density Lipoprotein
Roland, A., Patterson, R. A., & Leake, D. S. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.594 · Cited by 49
Schäfer, S., Pajonk, F., Multhaup, G., & Bayer, T. A. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0140-7 · Cited by 49
Alcaraz-Zubeldia, M., Rojas, P., Boll, C., & Ríos, C. (2001) · Neurochemical Research · doi:10.1023/a:1007680616056 · Cited by 48
Zhang, H., Wu, J.-S., & Peng, F. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282f2bdff · Cited by 48
Clioquinol – A Novel Copper-Dependent and Independent Proteasome Inhibitor
Schimmer, A. D. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519770 · Cited by 48
Huntington's disease: From molecular basis to therapeutic advances.
Krobitsch, S., & Kazantsev, A. (2011) · International Journal of Biochemistry and Cell Biology · doi:10.1016/j.biocel.2010.10.014 · Cited by 46
Copper complexes: a physiological approach to the treatment of ‘inflammatory diseases’
Sorenson, J. R. J., Kishore, V., Pezeshk, A., Oberley, L. W., Leuthauser, S. W. C., & Oberley, T. D. (1984) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)81851-4 · Cited by 46
Ahtoniemi, T., Goldsteins, G., Keksa-Goldsteine, V., Malm, T., Kanninen, K. M., Salminen, A., & Koıstınaho, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028415 · Cited by 45
The effects of topical tripeptide copper complex and helium-neon laser on wound healing in rabbits
Gul, N. Y., Topal, A., Cangul, I. T., & Yanik, K. (2008) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2007.00647.x · Cited by 41
Dietary copper supplementation reduces atherosclerosis in the cholesterol-fed rabbit
Lamb, D. J., Reeves, G. L., Taylor, A., & Ferns, G. A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00123-9 · Cited by 37
Fan, C., Zhao, J., Zhao, B., Zhang, S., & Miao, J. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900111y · Cited by 32
Rubio‐Osornio, M., Montes, S., Pérez‐Severiano, F., Aguilera, P., Floriano-Sánchez, E., Monroy‐Noyola, A., Rubio, C., & Ríos, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.01.019 · Cited by 31
Bica, L., Meyerowitz, J., Parker, S. J., Caragounis, A., Du, T., Paterson, B. M., Barnham, K. J., Crouch, P. J., White, A. R., & Donnelly, P. S. (2010) · BioMetals · doi:10.1007/s10534-010-9380-7 · Cited by 23
Self-citationPortas, A. D. S., Miguel, D. C., Yokoyama-Yasunaka, J. K. U., Uliana, S. R. B., & Espósito, B. P. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0834-3 · Cited by 21
Radovits, T., Gerő, D., Lin, L.-N., Loganathan, S., Hoppe‐Tichy, T., Szabó, C., Karck, M., Sakurai, H., & Szabo, G. B. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0762 · Cited by 18
Simón, D., Medina, M., Ávila, J., & Wandosell, F. G. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480401 · Cited by 16
Fujimori, T., Yasui, H., Hiromura, M., & Sakurai, H. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00595.x · Cited by 12
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
Targeting copper in cancer therapy: ‘Copper That Cancer’
Denoyer, D., Masaldan, S., La Fontaine, S., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 806
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, D. J., Adlard, P. A., Doble, P. A., & Finkelstein, D. I. (2013) · Metallomics · doi:10.1039/c2mt20164j · Cited by 78
Metadata
- Authors
- Duncan, C., & White, A. R.
- Venue
- Metallomics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012
- Volume
- 4
- Issue
- 2
- Pages
- 127-138
- ISSN
- 1756-5901 (ISSN-L)
- 1756-591X
- OpenAlex
- W2081544621
- Cited by
- 294
- References
- 114
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.